Evidence mapPaperPMID 40565011Full record

ArticleInternational journal of molecular sciences2025

Bioprinted Four-Cell-Type Lung Model for Viral Infection Studies Under Air-Liquid Interface Conditions.

Johanna Berg, Julian Heinze, Daniela Niemeyer, Josefin Hellgren, Himjyot Jaiswal, Anna Löwa, Andreas Hocke, Itedale Namro, Christian Drosten, Jens Kurreck and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Johanna BergDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.
Julian HeinzeGerman Center for Infection Research (DZIF), Charitéplatz 1, 10117 Berlin, Germany.
Daniela NiemeyerGerman Center for Infection Research (DZIF), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-1897-6365
Josefin HellgrenCellink, Långfilsgatan 1-7, 412 77 Gothenburg, Sweden.
Himjyot JaiswalCellink, Långfilsgatan 1-7, 412 77 Gothenburg, Sweden.
Anna LöwaDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-5551-731X
Andreas HockeDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Itedale NamroCellink, Långfilsgatan 1-7, 412 77 Gothenburg, Sweden.
Christian DrostenGerman Center for Infection Research (DZIF), Charitéplatz 1, 10117 Berlin, Germany.
Jens KurreckDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0002-1469-0052
Beatrice TolksdorfDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0002-1073-7503

Funding

Berlin University Alliance Excellence Strategy of the Federal Government and the LänderEinstein Foundation Berlin (Einstein Center 3R) EZ-2020-597-2Technische Universität Berlin ProTUTec
6 · The paper itself

Abstract

Viral lung infections are a never-ending threat to public health due to the emergence of new variants and their seasonal nature. While vaccines offer some protection, the need for effective antiviral drugs remains high. The existing research methods using 2D cell culture and animal models have their limitations. Human cell-based tissue engineering approaches hold great promise for bridging this gap. Here, we describe a microextrusion bioprinting approach to generate three-dimensional (3D) lung models composed of four cell types: endothelial cells, primary fibroblasts, macrophage cells, and epithelial cells. A549 and Calu-3 cells were selected as epithelial cells to simulate the cells of the lower and upper respiratory tract, respectively. Cells were bioprinted in a hydrogel consisting of alginate, gelatin, hyaluronic acid, collagen, and laminin-521. The models were cultured under air-liquid interface (ALI) conditions to further enhance their physiological relevance as lung cells. Their viability, metabolic activity, and expression of specific cell markers were analyzed during long-term culture for 21 days. The constructs were successfully infected with both a seasonal influenza A virus (IAV) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant, demonstrating their potential for studying diverse viral infections.

Indexed as

BioprintingCOVID-19LungA549 CellsEndothelial CellsEpithelial CellsFibroblastsHumansInfluenza A virusMacrophagesModels, BiologicalSARS-CoV-2Tissue Engineeringair–liquid interface culturebioprintinghuman lung modelinfluenza A virusSARS-CoV-2

Identifiers

PMID40565011
PMCPMC12193617

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.